Short Interest in Centogene (NASDAQ:CNTG) Decreases By 87.5%

Centogene (NASDAQ:CNTGGet Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 8,100 shares, a decrease of 87.5% from the January 15th total of 64,700 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 15,700 shares, the short-interest ratio is presently 0.5 days.

Centogene Stock Down 6.3 %

Centogene stock traded down $0.07 during trading on Monday, reaching $0.97. The stock had a trading volume of 8,985 shares, compared to its average volume of 16,896. Centogene has a 52-week low of $0.61 and a 52-week high of $2.52. The business has a 50 day moving average price of $1.18 and a 200 day moving average price of $1.13.

Centogene Company Profile

(Get Free Report)

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.

Recommended Stories

Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.